Companies / Applied Therapeutics, Inc.

Applied Therapeutics, Inc.

APLTCIK 1697532NEW YORK, NY

Financials · FY2024

Revenue$455.0K
Net income$-105.62M
Total debt—
Cash$11.95M
Diluted EPS$-0.76
Shares outstanding144.3M

Ownership

144.3M shares outstanding · as of Nov 12, 2025
100.0%Public float
Ownership
Public float100.00%144,300,674

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Bailey Evan PrescottChief Medical Officer
0.00%0
Chinoporos ConstantineSee Remarks
0.00%0
Funtleyder Leslie D.Chief Financial Officer · Director
0.00%0
Hooks Corwin DaleChief Commercial Officer
0.00%0
Kanter Stacy J.Director
0.00%0
Lerner TeenaDirector
0.00%0
Skyler Jay SDirector
0.00%0

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 19, 2025Funtleyder Leslie D.
Executive
GrantCommon Stock$0+1.2M
+88.59%
2,527,959
1.75% of shares
low
Jan 1, 2026Funtleyder Leslie D.
Executive
GrantCommon Stock$0+150K
+12.60%
1,340,459
0.93% of shares
low
Dec 19, 2025Hooks Corwin Dale
Executive
GrantCommon Stock$0+313K
+56.23%
868,253
0.60% of shares
low
Dec 19, 2025Chinoporos Constantine
Executive
GrantCommon Stock$0+438K
+70.61%
1,057,111
0.73% of shares
low
Dec 19, 2025Bailey Evan Prescott
Executive
GrantCommon Stock$0+438K
+50.91%
1,296,816
0.90% of shares
low
Feb 3, 2026Kanter Stacy J.
Director
OtherStock Option (Right to Buy)—-200K
-100.00%
0
0.00% of shares
low
Feb 3, 2026Kanter Stacy J.
Director
OtherStock Option (Right to Buy)—-17K
-100.00%
0
0.00% of shares
low
Feb 3, 2026Kanter Stacy J.
Director
OtherStock Option (Right to Buy)—-17K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vestal Point Capital, LPPassive13G/A———